Brief: 2cureX Gets Approval For Start Of Clinical Trial In Pancreatic Cancer
Nov 16 (Reuters) - 2cureX AB 2CUREX.ST :
* THE UNIVERSITY HOSPITAL, VEJLE HOSPITAL AND 2CUREX HAVE RECEIVED APPROVAL TO START A
CLINICAL
TRIAL IN PANCREATIC CANCER
* STUDY RESULTS TO BE COMPILED UP TO AND INCLUDING DEC 2023
Source text for Eikon: ID:nWkrbbKbRD
Further company coverage: 2CUREX.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))